Visual Outcomes and Patient Satisfactory After PanOptix Implantation in Hyperopic Cataract Patients

NCT05716269 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 44

Last updated 2023-02-08

No results posted yet for this study

Summary

To evaluate visual outcomes and patient satisfactory after PanOptix implantation in hyperopic cataract patients

Conditions

  • Cataract
  • Hyperopia

Sponsors & Collaborators

  • Tianjin Eye Hospital

    collaborator OTHER
  • Peking University Third Hospital

    lead OTHER

Principal Investigators

  • Hong Qi, MD, PhD · Peking University Third Hospital

Eligibility

Min Age
45 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-28
Primary Completion
2023-11-30
Completion
2023-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05716269 on ClinicalTrials.gov